Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPact of Inflammatory Arthritis on COVID-19 sTudy of the RAPPORT-ONTRAAC and FORCAST Rheumatic Disease Registries

NCT04347798 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04347798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04347798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPact of Inflammatory Arthritis on COVID-19 sTudy of the RAPPORT-ONTRAAC and FORCAST Rheumatic Disease Registries
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Completed
Start date
November 1, 2020
Completion date
June 30, 2022
Enrollment
773 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, hydroxychloroquine, psoriatic arthritis, rheumatoid arthritis